← Back
$ANTX All transactions

AN2 Therapeutics, Inc.

▲ BUY
7 / 10

Conviction

$ Value

$11K

Shares

10,000

Price

$1

Filed

Jun 3

Why this score? (7/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Easom Eric

Title

Chief Executive Officer

CIK

0001914503

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-02

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

256,380

Footnotes

This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.05 to $1.0699 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price. | Includes (i) 145,250 restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date and (ii) a balance of 99,000 RSUs which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of each such date. | Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019. | Consists of shares of Common Stock held by the C. Easom Irrevocable Trust dated October 8, 2021. | Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.

Filing Info

Accession No.

0000950170-25-081041

Form Type

4

Issuer CIK

0001880438

Easom Eric's History

Date Ticker Type Value
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-02-20 ANTX A $0
2026-02-20 ANTX A $0
2025-06-02 ANTX $11K

Other Insiders at ANTX (90d)

Insider Bought Sold Last
Zakrzewski Joseph S 2026-03-19
Spigelman Melvin K 2026-03-19
Wong Stephanie 2026-03-19
Chanda Sanjay
Chief Development Officer
2026-03-19
FitzPatrick Margaret M 2026-03-19
Easom Eric
Chief Executive Officer
2026-03-19
Day Lucy
Chief Financial Officer
2026-03-19
Aziz Kabeer 2026-04-10
Readnour Robin Shane 2026-03-19
Martin Patricia A. 2026-04-10
Marks Gilbert Lynn 2026-04-10
Eizen Joshua M
See Remarks
2026-03-19
Williams Sarah Joanne
Principal Accounting Officer
$347 2026-03-03